Amniotic Membrane Allograft Portfolio
Chronic and Hard-to-Heal Wounds
CommercialActive
Key Facts
About BioLab Holdings
BioLab Holdings, founded in 2018 and headquartered in Miami, is a private commercial-stage company in the tissue engineering and regenerative medicine sector. It has a portfolio of marketed wound care products, including amniotic membrane allografts and a synthetic antimicrobial matrix, targeting the chronic wound market. The company emphasizes a patient-first philosophy, partners with distributors and providers, and is experiencing team growth to support its commercial and R&D activities.
View full company profile